JP2011505361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505361A5 JP2011505361A5 JP2010536091A JP2010536091A JP2011505361A5 JP 2011505361 A5 JP2011505361 A5 JP 2011505361A5 JP 2010536091 A JP2010536091 A JP 2010536091A JP 2010536091 A JP2010536091 A JP 2010536091A JP 2011505361 A5 JP2011505361 A5 JP 2011505361A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- represented
- formula
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99100307P | 2007-11-29 | 2007-11-29 | |
| US60/991,003 | 2007-11-29 | ||
| PCT/US2008/084495 WO2009073432A1 (en) | 2007-11-29 | 2008-11-24 | Substituted cyclopentanes having prostaglandin activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014125190A Division JP2014221776A (ja) | 2007-11-29 | 2014-06-18 | プロスタグランジン活性を有する置換シクロペンタン類 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505361A JP2011505361A (ja) | 2011-02-24 |
| JP2011505361A5 true JP2011505361A5 (https=) | 2012-01-19 |
| JP5566902B2 JP5566902B2 (ja) | 2014-08-06 |
Family
ID=40456785
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536091A Expired - Fee Related JP5566902B2 (ja) | 2007-11-29 | 2008-11-24 | プロスタグランジン活性を有する置換シクロペンタン類 |
| JP2014125190A Abandoned JP2014221776A (ja) | 2007-11-29 | 2014-06-18 | プロスタグランジン活性を有する置換シクロペンタン類 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014125190A Abandoned JP2014221776A (ja) | 2007-11-29 | 2014-06-18 | プロスタグランジン活性を有する置換シクロペンタン類 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8158676B2 (https=) |
| EP (1) | EP2231162A1 (https=) |
| JP (2) | JP5566902B2 (https=) |
| AU (1) | AU2008331597B2 (https=) |
| BR (1) | BRPI0819707A2 (https=) |
| CA (1) | CA2706879A1 (https=) |
| WO (1) | WO2009073432A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9315486B2 (en) | 2013-10-29 | 2016-04-19 | Allergan, Inc. | Therapeutic cyclopentanols, compositions thereof, and methods for use thereof |
| JP2019513010A (ja) | 2016-03-04 | 2019-05-23 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | プロスタグランジンｅ２を用いる、筋再生のための組成物および方法 |
| WO2018227138A1 (en) | 2017-06-09 | 2018-12-13 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for preventing or treating muscle conditions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4259516A (en) * | 1979-04-02 | 1981-03-31 | The Upjohn Company | 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds |
| US20020013304A1 (en) * | 1997-10-28 | 2002-01-31 | Wilson Leland F. | As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| US6090847A (en) | 1997-11-21 | 2000-07-18 | Allergan Sales, Inc. | EP2 -receptor agonists as neuroprotective agents for the eye |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| BRPI0605926A2 (pt) * | 2005-01-14 | 2009-05-26 | Allergan Inc | ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos |
| US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| US7476755B2 (en) * | 2006-05-04 | 2009-01-13 | Allergan, Inc. | Therapeutic compounds |
| US20080015219A1 (en) * | 2006-07-11 | 2008-01-17 | Allergan, Inc. | Therapeutic compounds |
| US20110152328A1 (en) * | 2008-04-16 | 2011-06-23 | Whitcup Scott M | Combination Therapy For Glaucoma |
-
2008
- 2008-11-24 JP JP2010536091A patent/JP5566902B2/ja not_active Expired - Fee Related
- 2008-11-24 CA CA2706879A patent/CA2706879A1/en not_active Abandoned
- 2008-11-24 AU AU2008331597A patent/AU2008331597B2/en not_active Ceased
- 2008-11-24 WO PCT/US2008/084495 patent/WO2009073432A1/en not_active Ceased
- 2008-11-24 US US12/276,491 patent/US8158676B2/en active Active
- 2008-11-24 BR BRPI0819707-5A patent/BRPI0819707A2/pt not_active IP Right Cessation
- 2008-11-24 EP EP08858242A patent/EP2231162A1/en not_active Withdrawn
-
2012
- 2012-03-19 US US13/423,500 patent/US8546603B2/en active Active
-
2014
- 2014-06-18 JP JP2014125190A patent/JP2014221776A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009114217A5 (https=) | ||
| JP2011500818A5 (https=) | ||
| JP2009543795A5 (https=) | ||
| JP2016518434A5 (https=) | ||
| JP2010534247A5 (https=) | ||
| JP2010280669A5 (https=) | ||
| JP2018518537A5 (https=) | ||
| JP2007534702A5 (https=) | ||
| JP2010500976A5 (https=) | ||
| JP2009543794A5 (https=) | ||
| JP2010518128A5 (https=) | ||
| JP2011527691A5 (https=) | ||
| JP2008543854A5 (https=) | ||
| JP2014509612A5 (https=) | ||
| JP2009535426A5 (https=) | ||
| JP2010500416A5 (https=) | ||
| JP2010540477A5 (https=) | ||
| RU2014105895A (ru) | Терапевтические замещенные циклопентаны для уменьшения внутриглазного давления | |
| JP2009543792A5 (https=) | ||
| JP2010505865A5 (https=) | ||
| JP2012177087A5 (https=) | ||
| JP2011505361A5 (https=) | ||
| JP2019507105A5 (https=) | ||
| RU2012144438A (ru) | Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза | |
| JP2011503089A5 (https=) |